Authors:
JACQUET A
HAUMONT M
CHELLUN D
MASSAER M
TUFARO F
BOLLEN A
JACOBS P
Citation: A. Jacquet et al., THE VARICELLA-ZOSTER VIRUS GLYCOPROTEIN-B (GB) PLAYS A ROLE IN VIRUS BINDING TO CELL-SURFACE HEPARAN-SULFATE PROTEOGLYCANS, Virus research, 53(2), 1998, pp. 197-207
Citation: A. Jacquet et R. Morlat, CHARACTERIZATION OF THE CLIMATIC VARIABIL ITY IN THE LOIRE VALLEY VINEYARD - INFLUENCE OF LANDSCAPE AND PHYSICAL CHARACTERISTICS OF THE ENVIRONMENT, Agronomie, 17(9-10), 1997, pp. 465-480
Authors:
HAUMONT M
JURDAN M
KANGRO H
JACQUET A
MASSAER M
DELEERSNYDER V
GARCIA L
BOSSELOIR A
BRUCK C
BOLLEN A
JACOBS P
Citation: M. Haumont et al., NEUTRALIZING ANTIBODY-RESPONSES INDUCED BY VARICELLA-ZOSTER VIRUS GE AND GB GLYCOPROTEINS FOLLOWING INFECTION, REACTIVATION OR IMMUNIZATION, Journal of medical virology, 53(1), 1997, pp. 63-68
Authors:
TOURNAY C
COURTOY PJ
MARODI L
TOTTE P
WERENNE J
JACQUET A
GARCIAQUINTANA L
BOLLEN A
MOGUILEVSKY N
Citation: C. Tournay et al., UPTAKE OF RECOMBINANT MYELOPEROXIDASE, FREE OR FUSED TO FC-GAMMA, BY MACROPHAGES ENHANCES KILLING ACTIVITY TOWARD MICROORGANISMS, DNA and cell biology, 15(8), 1996, pp. 617-624
Authors:
HAUMONT M
JACQUET A
MASSAER M
DELEERSNYDER V
MAZZU P
BOLLEN A
JACOBS P
Citation: M. Haumont et al., PURIFICATION, CHARACTERIZATION AND IMMUNOGENICITY OF RECOMBINANT VARICELLA-ZOSTER VIRUS GLYCOPROTEIN GE SECRETED BY CHINESE-HAMSTER OVARY CELLS, Virus research, 40(2), 1996, pp. 199-204
Authors:
JACQUET A
ROUSSILHES R
ANOUFA S
MARTEAU C
MALLET F
AUDEBERT A
Citation: A. Jacquet et al., STUDY OF A NEW PH 5.2-ASTERISK LACTOSERUM LACTIC-ACID EMULSION FOR FEMININE HYGIENE - RESULTS OF A CLINICAL-STUDY, Contraception fertilite sexualite, 23(7-8), 1995, pp. 457-459
Authors:
JACQUET A
MASSAER M
HAUMONT M
HOUARD S
DELEERSNYDER V
PLACE M
BOLLEN A
JACOBS P
Citation: A. Jacquet et al., PURIFICATION AND CHARACTERIZATION OF RECOMBINANT VARICELLA-ZOSTER VIRUS GLYCOPROTEIN GPII, SECRETED BY CHINESE-HAMSTER OVARY CELLS, Protein expression and purification, 6(1), 1995, pp. 91-98
Citation: C. Davey et al., CHARACTERIZATION OF THE HEME-PROTEIN COVALENT BONDS IN HUMAN MYELOPEROXIDASE BY X-RAY CRYSTALLOGRAPHY AND SITE-DIRECTED MUTAGENESIS, Protein engineering, 8, 1995, pp. 112-112
Authors:
FLORIS R
MOGUILEVSKY N
PUPPELS G
JACQUET A
RENIRIE R
BOLLEN A
WEVER R
Citation: R. Floris et al., HEME PROTEIN-INTERACTION IN MYELOPEROXIDASE - MODIFICATION OF SPECTROSCOPIC PROPERTIES AND CATALYTIC ACTIVITY BY SINGLE RESIDUE MUTATION, Journal of the American Chemical Society, 117(14), 1995, pp. 3907-3912
Authors:
JACQUET A
GARCIAQUINTANA L
DELEERSNYDER V
FENNA R
BOLLEN A
MOGUILEVSKY N
Citation: A. Jacquet et al., SITE-DIRECTED MUTAGENESIS OF HUMAN MYELOPEROXIDASE - FURTHER IDENTIFICATION OF RESIDUES INVOLVED IN CATALYTIC ACTIVITY AND HEME INTERACTION, Biochemical and biophysical research communications, 202(1), 1994, pp. 73-81
Authors:
JACQUET A
COLOMES M
FERRIERES J
DENAT M
DOUSTEBLAZY P
MONSTASTRUC JL
Citation: A. Jacquet et al., A ONE-YEAR PROSPECTIVE AND INTENSIVE STUD Y OF PHARMACOVIGILANCE IN AN HOSPITAL OUTPATIENT-CLINIC FOR PREVENTION OF RISK-FACTORS, Therapie, 48(5), 1993, pp. 509-512
Citation: A. Jacquet et al., POSTMARKETING SURVEILLANCE (PHARMACOVIGILANCE) OF ANTIHYPERTENSIVE DRUGS BETWEEN 1981 AND 1990 IN A TEACHING HOSPITAL, Therapie, 48(2), 1993, pp. 141-144